Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma
Alexander C. J. van Akkooi(The University of Sydney), Alexander M.M. Eggermont(University Medical Center Utrecht), Marna G. Bouwhuis(Erasmus MC), Mike Kliffen(Maasstad Ziekenhuis), Paul Schmitz(University Hospital Regensburg), Johannes H. W. de Wilt(Radboud University Nijmegen)
Cited by 60
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k